News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Catalent and GelMEDIX form global partnership to advance iPSC-derived cell therapies for ocular and retinal diseases
Thursday, March 12, 2026GelMEDIX and Catalent have entered a global partnership to support the development and clinical manufacturing of induced pluripotent stem cell iPSCderived therapies aimed at treating ocular and retinal diseases
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Thursday, March 12, 2026The European Commissions Health Package progresses with the EU Biotech Act offering SPC extensions for biotechs and faster clinical trial approvals to enhance life sciences competitiveness
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Wednesday, March 11, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
Curatis and Neupharma Sign Exclusive Licensing Deal to Develop Corticorelin for Brain Oedema Treatment in Japan
Wednesday, March 11, 2026Curatis Holding AG and Neupharma Co Ltd have signed an exclusive licensing and development agreement for corticorelin CPTBE in Japan
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Tuesday, March 10, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
NewcelX collaborates with Eledon Pharmaceuticals to advance NCEL-101 programme for Type 1 diabetes
Tuesday, March 10, 2026NewcelX Ltd has announced a research collaboration with Eledon Pharmaceuticals Inc to support the development of its NCEL programme for the treatment of Type diabetes
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Monday, March 09, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Friday, March 06, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Thursday, March 05, 2026The European Commission has introduced a comprehensive Health Package including the first phase of the EU Biotech Act and amendments to clinical trials regulation to boost competitiveness and resilience in life sciences
Vericel Receives FDA Approval for Advanced Therapy Manufacturing Plant
Thursday, March 05, 2026Vericel Corporation has received approval from the US Food and Drug Administration to begin commercial manufacturing of MACI at its advanced cell therapy manufacturing plant in Burlington Massachusetts
